Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 331

1.

Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.

Beilke MA, Theall KP, O'Brien M, Clayton JL, Benjamin SM, Winsor EL, Kissinger PJ.

Clin Infect Dis. 2004 Jul 15;39(2):256-63. Epub 2004 Jun 25.

PMID:
15307036
2.

Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS.

Turci M, Pilotti E, Ronzi P, Magnani G, Boschini A, Parisi SG, Zipeto D, Lisa A, Casoli C, Bertazzoni U.

J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):100-6.

PMID:
16340481
3.

Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.

Casoli C, Pilotti E, Bertazzoni U.

AIDS Rev. 2007 Jul-Sep;9(3):140-9. Review.

PMID:
17982939
4.

An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users.

Hershow RC, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G, Klein RS, Des Jarlais DC, Vitek C, Khabbaz R, Freels S, Zuckerman R, Pezzotti P, Kaplan JE.

J Infect Dis. 1996 Aug;174(2):309-17.

PMID:
8699060
5.
6.

Retroviral coinfections at a New Orleans HIV outpatient clinic.

Bessinger R, Beilke M, Kissinger P, Jarrott C, Tabak OF.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1;14(1):67-71.

PMID:
8989213
7.

HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.

Brites C, Sampalo J, Oliveira A.

AIDS Rev. 2009 Jan-Mar;11(1):8-16. Review.

PMID:
19290030
8.

HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users.

Visconti A, Visconti L, Bellocco R, Binkin N, Colucci G, Vernocchi L, Amendola M, Ciaci D.

J Acquir Immune Defic Syndr. 1993 Nov;6(11):1228-37.

PMID:
7901382
9.

Laboratory study of HIV-1 and HTLV-I/II coinfection.

Beilke MA, Greenspan DL, Impey A, Thompson J, Didier PJ.

J Med Virol. 1994 Oct;44(2):132-43.

PMID:
7852953
10.

T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).

Casseb J, Posada-Vergara MP, Montanheiro P, Fukumori LM, Olah I, Smid J, Duarte AJ, Penalva de Oliveira AC.

Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):231-3.

11.

Increased risk of developing peripheral neuropathy in patients coinfected with HIV-1 and HTLV-2.

Zehender G, Colasante C, Santambrogio S, De Maddalena C, Massetto B, Cavalli B, Jacchetti G, Fasan M, Adorni F, Osio M, Moroni M, Galli M.

J Acquir Immune Defic Syndr. 2002 Dec 1;31(4):440-7.

PMID:
12447016
12.

HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau.

Norrgren H, Andersson S, Nauclér A, Dias F, Johansson I, Biberfeld G.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):422-8.

PMID:
7600111
13.

Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.

Bassani S, López M, Toro C, Jiménez V, Sempere JM, Soriano V, Benito JM.

Clin Infect Dis. 2007 Jan 1;44(1):105-10. Epub 2006 Nov 21.

PMID:
17143825
14.

Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.

Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ.

Clin Infect Dis. 2007 May 1;44(9):1229-34. Epub 2007 Mar 19.

PMID:
17407044
15.
16.

Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression.

Giacomo M, Franco EG, Claudio C, Carlo C, Anna DA, Anna D, Franco F.

Eur J Epidemiol. 1995 Oct;11(5):527-33.

PMID:
8549726
17.

Effects of retroviral infections on immune function in African-American intravenous drug users.

Klimas NG, Page JB, Patarca R, Chitwood D, Morgan R, Fletcher MA.

AIDS. 1993 Mar;7(3):331-5.

PMID:
8471194
19.

HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1.

Schechter M, Moulton LH, Harrison LH.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 1;15(4):308-11.

PMID:
9292591
20.

Effects of human T-lymphotropic virus type II on human immunodeficiency virus type 1 phenotypic evolution.

Guenthner PC, Hershow RC, Lal RB, Dezzutti CS.

Arch Virol. 2001 Aug;146(8):1617-22.

PMID:
11676422

Supplemental Content

Support Center